|
You are here: Home: BCU 6|2002: Editor's
Note: Select publications
Anastrozole alone or in combination with tamoxifen versus
tamoxifen alone for adjuvant treatment of postmenopausal women with
early breast cancer: First results of the ATAC randomised trial.
Lancet 2002;359;2131-39. Abstract
Jones S. Fulvestrant ('Faslodex®') versus anastrozole
('Arimidex®') for the treatment of advanced breast cancer in
postmenopausal women – safety update on the combined analysis
of two multicenter trials. Breast Cancer Res Treat 2001;Abstract
455.
Parker LM et al. Greater duration of response in patients
receiving fulvestrant (‘Faslodex’) compared with those
receiving anastrozole (‘Arimidex’). Proc ASCO
2002;Abstract
160.
Robertson JF. Estrogen receptor downregulators: New antihormonal
therapy for advanced breast cancer. Clin Ther 2002;24 Suppl
A:A17-30. Abstract
|
